1. China Stocks

  2. •

    Health technology

  3. •

    Medical specialties
LifeTech Scientific Corporation

LifeTech Scientific Corporation

HHKEX:1302
1.52
HKD
-0.03
(-1.94%)
6.87BMarket Cap
Mar 31Next Earn
2013 Y
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
TTM
Revenue per Share
0.06
0.07
0.08
0.09
0.09
0.13
0.16
0.15
0.21
0.26
0.29
0.3
0.31
- -
Basic EPS, GAAP
-0.02
-0.02
- -
0.04
0.04
0.03
0.03
0.05
0.07
0.08
0.06
0.05
0.03
- -
Free Cash Flow per Basic Share
-0.01
-0.01
-0.02
- -
- -
0.02
0.03
0.04
0.02
0.01
0.03
0.01
0.09
- -
Dividend per Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Book Value per Share
0.06
0.04
0.05
0.2
0.24
0.29
0.27
0.51
0.54
0.63
0.77
0.79
0.8
0.8
Tangible Book Value per Share
0.05
0.02
0.03
0.18
0.21
0.24
0.21
0.44
0.46
0.53
0.62
0.63
0.62
0.62
Basic Weighted Avg Shares
4,000
4,000
4,000
4,003
4,325
4,334
4,140
4,338
4,309
4,233
4,356
4,379
4,370
4,365
Sales/Revenue/Turnover
231
283
312
353
409
557
669
642
925
1,097
1,267
1,304
1,370
- -
Operating Margin (%)
20.53
20.03
29.81
28.54
45.78
21.12
17.79
6.4
35.3
31.26
23.24
13.86
12.84
- -
Depreciation Expense
7
7
8
10
17
33
55
63
62
67
77
88
103
- -
Net Income, GAAP
-66
-81
2
146
163
121
129
216
292
325
263
222
148
- -
Effective Tax Rate (%)
- -
- -
84.75
22.06
15.52
27.42
25.55
14.67
14.89
15.69
38.78
15.33
41.3
- -
Profit Margin (%)
-28.42
-28.74
0.76
41.28
39.96
21.75
19.32
33.64
31.61
29.65
20.77
17.06
10.79
- -
Working Capital
287
322
280
591
450
370
265
1,051
1,355
812
1,461
1,519
846
846
LT Debt
67
78
145
180
- -
22
228
5
5
5
3
1
4
4
Total Equity
236
156
180
871
1,056
1,244
1,162
2,358
2,530
2,921
3,324
3,475
3,475
3,475
Return on Invested Capital (%)
- -
- -
4.8
11.46
14.67
9.93
9.81
10.94
10.85
11.41
7.38
4.57
3.08
- -
Return on Capital (%)
- -
- -
0.97
22.65
15.43
10.41
10.51
12.17
11.94
12.14
13.39
8.16
5.27
- -
Return on Common Equity (%)
-24.87
-42.45
1.42
27.8
17.02
10.56
10.8
12.38
12.08
12.04
8.4
6.48
4.22
- -

Capital Structure

CNY

•

in mil. unless spec.
Dec'24
Jun'25
Dec'25
ST Debt
4
3
4
LT Borrowings
- -
- -
- -
LT Finance Leases
1
1
4
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
4,400
4,401
4,401
Market Capitalization
5,747
8,153
6,169

Working Capital

CNY

•

in mil. unless spec.
Dec'24
Jun'25
Dec'25
Total Current Assets
2,334
2,573
2,325
Cash, Cash Equivalents & STI
1,182
1,395
1,150
Accounts Receivable, Net
137
205
162
Inventories
532
494
445
Total Current Liabilities
816
993
1,479
Payables & Accruals
- -
- -
- -
ST Debt
4
3
4
Deferred Revenue
- -
- -
- -

Growth Rates

CNY

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
55.95%
8.21%
-0.01%
Free Cash Flow
432.15%
182.76%
937.55%
Net Income, GAAP
611.3%
-4.31%
-33.53%
Sales/Revenue/Turnover
16.75%
17.22%
5.07%
Total Cash Common Dividend
- -
- -
- -

Semi-annual Revenue

CNY

•

in mil. unless spec.

Year

H1
H2
FY
2023
- -
- -
1,267
2024
- -
- -
1,304
2025
- -
- -
1,370

Semi-annual Earnings Per Share

CNY

•

in mil. unless spec.

Year

H1
H2
FY
2023
- -
- -
0.06
2024
- -
- -
0.05
2025
- -
- -
0.03

Semi-annual Dividends Per Share

CNY

•

in mil. unless spec.

Year

H1
H2
FY
2023
- -
- -
- -
2024
- -
- -
- -
2025
- -
- -
- -

Company Description

Company Profile APIChatGPT
CEO
Yue Hui Xie
Full Time Employees
1,240
Sector
Health technology
Industry
Medical specialties
Address
LifeTech Scientific Building Shenzhen China 518063
IPO Date
Nov 10, 2011
Website
lifetechmed.com
Similar Companies
Intuitive Surgical, Inc. (NASDAQ:ISRG)
Boston Scientific Corporation (NYSE:BSX)
Thermo Fisher Scientific Inc (NYSE:TMO)
Illumina, Inc. (NASDAQ:ILMN)
Abbott Laboratories (NYSE:ABT)
GRAIL, Inc. (NASDAQ:GRAL)
Business
LifeTech Scientific Corporation (Ticker: LFTSF) is a medical device company primarily engaged in the manufacturing, marketing, and sale of minimally invasive surgical products and medical instruments. Its product portfolio includes advanced stapling devices; surgical staplers and reloads; endoscopic surgical instruments; biologic and synthetic surgical meshes; hernia repair products; and wound closure technology. LifeTech also provides comprehensive solutions in laparoscopic and thoracic surgery tools, covering multiple surgical specialties. The company operates globally, serving hospitals and surgery centers across key international markets, with headquarters located in China. In the past 1-2 years, LifeTech has notably expanded its product offerings by launching new surgical staplers and enhanced minimally invasive surgical solutions designed to improve procedural efficiency and patient outcomes. The company has also pursued strategic partnerships to strengthen its distribution network and accelerate innovation in surgical technologies. Key operational changes include increased investment in research and development, as well as an expansion of its direct sales force to better serve diverse geographic markets. These efforts underscore LifeTech’s commitment to maintaining a leading position in the global medical technology sector. Founded in 2003, LifeTech Scientific Corporation operates primarily within the medical devices and healthcare industries, targeting surgeons, hospitals, and healthcare providers that require advanced surgical equipment. The company also manages subsidiary entities that specialize in specific product lines and regional sales operations, enhancing its market reach and operational efficiency. Overall, LifeTech Scientific Corporation offers a comprehensive suite of surgical products and technologies that support minimally invasive surgery, wound management, and hernia repair, backed by ongoing innovations and strategic growth activities to sustain its competitive edge in the global medical devices market.